SBIO:ARCA-ALPS Medical Breakthroughs (USD)

ETF | Health | NYSE Arca

Last Closing

USD 37.413

Change

0.00 (0.00)%

Market Cap

USD 0.12B

Volume

1.95K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks total return, with an emphasis on income as the source of that total return. The fund seeks to achieve its investment objective by investing in a global portfolio of fixed income securities of various maturities, ratings and currency denominations. The adviser intends to utilize various investment strategies in a broad array of fixed income sectors. The fund may purchase fixed income securities issued by U.S. or foreign corporations or financial institutions, including debt securities of all types and maturities, convertible securities and preferred stocks. It is non-diversified.

Inception Date: 30/12/2014

Primary Benchmark: Poliwogg Medical Breakthroughs TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.5%

Management Expense Ratio: 0.50 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
CRTTF Cortus Metals Inc 2.56 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV Health Care Select Sector SPDR.. 0.13 %

+0.32 (+0.21%)

USD 42.19B
FHLC Fidelity® MSCI Health Care In.. 0.08 %

+0.19 (+0.26%)

USD 3.02B
FXH First Trust Health Care AlphaD.. 0.63 %

+0.86 (+0.77%)

USD 1.26B
XHE SPDR® S&P Health Care Equipme.. 0.35 %

+1.16 (+1.31%)

USD 0.22B
IDNA iShares Genomics Immunology an.. 0.00 %

+0.65 (+2.67%)

USD 0.14B
XHS SPDR® S&P Health Care Service.. 0.35 %

+1.71 (+1.78%)

USD 0.08B
HTEC Robo Global® Healthcare Techn.. 0.00 %

+0.32 (+1.10%)

USD 0.06B
BBP Virtus LifeSci Biotech Product.. 0.79 %

+1.33 (+2.12%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica.. 0.79 %

+0.96 (+3.42%)

USD 0.01B
IHE iShares U.S. Pharmaceuticals E.. 0.42 %

+0.35 (+0.49%)

N/A

ETFs Containing SBIO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.58% 76% C+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.58% 76% C+ 71% C-
Trailing 12 Months  
Capital Gain 23.42% 95% A 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.42% 95% A 78% C+
Trailing 5 Years  
Capital Gain 8.76% 57% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.76% 57% F 54% F
Average Annual (5 Year Horizon)  
Capital Gain -0.88% N/A N/A 33% F
Dividend Return -0.84% N/A N/A 21% F
Total Return 0.04% N/A N/A 1% F
Risk Return Profile  
Volatility (Standard Deviation) 26.48% N/A N/A 39% F
Risk Adjusted Return -3.16% N/A N/A 24% F
Market Capitalization 0.12B 50% F 29% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.